COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 142: Articles 1411-1420  | Next

Dutch participatory surveillance framework for evaluating evolutionary changes on SARS-CoV-2 affecting Rapid Diagnostic Test sensitivity in 2022 - 2023.
Kozanli, E., Han, W., Smit, T., de Bakker, J., Elahi, M., Jaarsma, R., Carstens, G., van Hoek, A. J., Eggink, D.
10.1101/2024.09.10.24313404 — Posted: 2024-09-10
5-hydroxymethylcytosine Epigenetic Markers in COVID-19-Associated Acute Coronary Syndrome: Insights into Neutrophil Activation and PDE4D Upregulation
Li, Z., Duolikun, M., Chen, H., Zhang, L., Liu, Y., Li, R., Li, D., Chen, L., sun, l.
10.1101/2024.09.09.24313367 — Posted: 2024-09-10
Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022/2023 respiratory season in the Netherlands
Carstens, G., Kozanli, E., Bulsink, K., McDonald, S., Elahi, M., de Bakker, J., Schipper, M., van Gageldonk-Lafeber, R., van den Hof, S., van Hoek, A. J., Eggink, D.
10.1101/2024.09.10.24313400 — Posted: 2024-09-10
The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops is Determined by Ligand Binding and Interprotomer Allostery
Lee, E., Rauscher, S.
10.1101/2024.09.09.612101 — Posted: 2024-09-10
Reversible Transcriptomic Age Shifts from Physiological Stress in Whole Blood
Bhak, J., Nam, D., An, K., Kwon, Y., Bhak, J., Jeon, S., Ryu, H.
10.1101/2024.09.08.611853 — Posted: 2024-09-09
COVID-19 real world data infrastructure: A big data resource for study of the impact of COVID-19 in patient populations with immunocompromising conditions
Crawford, J. M., Penberthy, L., Pinto, L. A., Althoff, K. N., Assimon, M. M., Cohen, O., Gillim, L., Hammonds, T. L., Kapur, S., Kaufman, H. W., Kwasny, D., Liew, J. W., Meyer, W. A., Reynolds, S. L., Schleicher, C. B., Subbiah, S., Theruviparampil, C., Wallace, Z. S., Warner, J. L., Yoon, N., Ziemba, Y. C.
10.1101/2024.09.08.24313270 — Posted: 2024-09-09
Epidemiological profile of patients diagnosed with covid-19 in the municipality of Sao Goncalo, Rio de Janeiro, Brazil
das Chagas, R. R., Freitas, H. R., Cardozo, S. V.
10.1101/2024.09.08.24313185 — Posted: 2024-09-09
Adapting COVID-19 research infrastructure to capture influenza and RSV alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Evaluation of the SIREN Winter Pressures pilot study
Munro, K., Russell, S., Foulkes, S., Broad, J., Sparkes, D., Atti, A., Islam, J., Hopkins, S., Hall, V., SIREN study group
10.1101/2024.09.08.24313279 — Posted: 2024-09-09
Efficacy of Molnupiravir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Gentile, I., Scotto, R., Scirocco, M. M., Di Brizzi, F., Cuccurullo, F., Silvitelli, M., Ametrano, L., Alfe', F. A., Pietroluongo, D., Irace, I., Chiariello, M., De Felice, N., Severino, S., Viceconte, G., Schiano Moriello, N., Maraolo, A. E., Buonomo, A. R., Giaccone, A., Federico II COVID Team
10.1101/2024.09.09.24313305 — Posted: 2024-09-09
Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative model
Shang, J., Ran, T., Lu, Y., Yang, Q., Zhang, G., Zhou, P., Li, W., Xu, M., Dai, M., Zhong, J., Chen, H., He, P., Zhou, A., Xue, B., Chen, J., Zhang, J., Wu, K., Wu, X., Tang, M., Chen, X., Chen, H.
10.1101/2024.09.07.611841 — Posted: 2024-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).